Pages
Patient Safety
Patient Safety is the freedom from harm in healthcare and is a process by which an organisation makes patient care safer.
https://dchs.nhs.uk/about-us/quality-heart-our-care/patient-safety
Accessible information standards
https://dchs.nhs.uk/about-us/equality-diversity-inclusion/accessible-information
Interpreting & translation
https://dchs.nhs.uk/about-us/equality-diversity-inclusion/interpreting-translation
Diabetes Education Service
If you have type 2 diabetes, attending an education programme is an important part of your treatment plan.
Diabetes Education for Professionals
The information here is for professionals in Derbyshire working with patients with type 2 diabetes.
Research and Innovation
Our vision is to increase capacity, capability and participation in research and innovation as we embed a culture of continuous improvement across the organisation.
Files
Competency Reassessment Sign Off and Declaration Form - G322 Appendix 1
Competency Reassessment Sign Off and Declaration Form
Disclosure Ref 2024134 - Nurse Associate Job Description Band 4.pdf
Disclosure Ref 2024134 - Nurse Associate Job Description Band 4
HRP37 Managing Allegations Against Staff PiPoT Policy - Appendix 1 - Flowchart – Internal PIPOT Process
HRP37 Managing Allegations Against Staff PiPoT Policy - Appendix 1 - Flowchart – Internal PIPOT Process
What seating can do for you (L330)
What seating can do for you
PGD 152C Morphine Sulfate Oral Solution for Children (UTC).pdf
PGD 152C Morphine Sulphate for Children (UTC)
Dementia Palliative Care Service Patient Leaflet – Transitional Nurse (L331)
Dementia Palliative Care Service Patient Leaflet – Transitional Nurse
L334 - North East Derbyshire Type 2 Diabetes Education and Support
North East Derbyshire Type 2 Diabetes Education and Support (L334)
A7 - Administration of Enteral Feed Product (P48)
Administration of Enteral Feed Product
Locked Box Pathway (G335)
Locked Box Pathway
Disclosure Ref 202542 - Internal review investigation report Jan 25 1 of 2.pdf
Freedom of Information disclosure ref 202542 Internal review investigation report Jan 25 1 of 2